In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release

被引：0

作者：

Josep M. Casanovas

Olivier Berton

Pau Celada

Francesc Artigas

机构：

[1] Department of Neurochemistry,

[2] Institut d'Investigacions Biomèdiques de Barcelona (CSIC),undefined

[3] IDIBAPS,undefined

[4] 6th floor,undefined

[5] Rosselló,undefined

[6] 161,undefined

[7] E-08036 Barcelona,undefined

[8] Spain,undefined

[9] Present address: UCB Pharma,undefined

[10] Preclinical CNS Research Group,undefined

[11] Braine-l'Alleud,undefined

[12] Belgium,undefined

来源：

Naunyn-Schmiedeberg's Archives of Pharmacology | 2000年 / 362卷

关键词：

5-HT1A receptors Dorsal raphe nucleus Hippocampus Median raphe nucleus Microdialysis Prefrontal cortex Single unit recordings;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We investigated the effects of the novel 5-HT1A receptor agonist BAY x 3702 on the serotonergic function in rat brain using single unit recordings in the dorsal raphe nucleus (DR) of anesthetized rats and in vivo microdialysis in freely moving rats. The administration of BAY x 3702 (0.25–4 µg/kg i.v.) suppressed the firing activity of 5-HT neurones. This effect was antagonized by a low dose of the selective 5-HT1A receptor antagonist WAY 100635 (5 µg/kg i.v.).

引用

页码：248 / 254

页数：6

共 50 条

[31] Occupancy of agonist drugs at the 5-HT1A receptor
Bantick, RA
Rabiner, EA
Hirani, E
de Vries, MH
Hume, SP
Grasby, PM
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 847 - 859
[32] Regulation of agonist efficacy at the 5-HT1A receptor
McLoughlin, DJ
Evans, KJ
Clarke, WP
FASEB JOURNAL, 2001, 15 (04): : A219 - A219
[33] Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats
Koyama, T
Nakajima, Y
Fujii, T
Kawashima, K
NEUROSCIENCE LETTERS, 1999, 265 (01) : 33 - 36
[34] Population Pharmacokinetics of the Selective Serotonin 5-HT1A Receptor Partial Agonist Piclozotan
Mondick, John I.
Oo, Charles
Patel, Dimple
Fujitani, Tomomichi
Shimizu, Kahori
Barrett, Jeffrey S.
AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (02) : 106 - 115
[35] Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist
De Vry, J
Schohe-Loop, R
Heine, HG
Greuel, JM
Mauler, F
Schmidt, B
Sommermeyer, H
Glaser, T
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (03): : 1082 - 1094
[36] F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity
Assie, Marie-Bernadette
Bardin, Laurent
Auclair, Agnes L.
Carilla-Durand, Elisabeth
Depoortere, Ronan
Koek, Wouter
Kleven, Mark S.
Colpaert, Francis
Vacher, Bernard
Newman-Tancredi, Adrian
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (10): : 1285 - 1298
[37] Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body temperature:: modification by the selective 5-HT1A receptor antagonist WAY 100635
Cryan, JF
Kelliher, P
Kelly, JP
Leonard, BE
JOURNAL OF PSYCHOPHARMACOLOGY, 1999, 13 (03) : 278 - 283
[38] The 5-HT1A receptor as a serotonergic target for neuroprotection in cerebral ischemia
de Aguiar, Rafael Pazinatto
Newman-Tancredi, Adrian
Prickaerts, Jos
Weffort de Oliveira, Rubia Maria
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 109
[39] Efficacy of a 5-HT1a receptor agonist in atopic dermatitis
Kawana, S.
Kato, Y.
Omi, T.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (08) : 835 - 840
[40] Fluorinated (R)-(-)-aporphines as potential agonist positron emission tomography ligands for serotonergic 5-HT1A receptor
Xu, Yulong
Sromek, Anna
Neumeyer, John
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256

← 1 2 3 4 5 →